Corcept Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
MYOKMyoKardia, Inc. 0.37%222.971.8%$514.75m
HZNPHorizon Therapeutics Plc 1.81%77.445.8%$157.77m
VRXValeant Pharmaceuticals International, Inc. 2.00%18.3614.1%$108.03m
JAZZJazz Pharmaceuticals Plc -0.61%150.262.4%$80.09m
CTLTCatalent, Inc. 0.69%94.042.1%$78.96m
BHCBausch Health Cos., Inc. 2.00%18.360.0%$69.59m
UTHRUnited Therapeutics Corp. 0.56%122.7814.1%$49.00m
ICLRICON plc -1.87%194.354.3%$47.08m
SAGESAGE Therapeutics, Inc. 0.97%71.518.6%$44.61m
ENDPEndo International Plc 0.00%5.798.7%$38.62m
ARGXargenx SE -0.72%250.420.0%$37.39m
ZGNXZogenix, Inc. 1.38%21.297.5%$35.17m
AMRNAmarin Corp. Plc -0.80%4.981.5%$33.35m
PRGOPerrigo Co. Plc 0.26%45.606.8%$32.08m
CTICCTI BioPharma Corp. 4.79%3.501.8%$31.00m

Company Profile

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.